Artificial intelligence is no longer a side conversation in gastroenterology. It is moving to the center of operations — and future competitive advantage. In this episode of The Scope Forward Show, I sit down with Dr. Michael Dragutsky (Chairman, One GI), Christa Newton (CEO, One GI), Aniket Behera (COO and Co-founder, 100ms), and Satish Malnaik (CEO, NextServices). We…
FUJIFILM Healthcare Europe has announced that its latest 800-series duodenoscopes are now compatible with a newly CE-mark–approved sterilization cycle —…
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening…
From seismic policy shifts to blockbuster deals and the accelerating migration of higher-acuity care into the outpatient setting, 2025 was…
Earlier this year the Centers for Medicare and Medicaid Services introduced the “Wasteful and Inappropriate Service Reduction” model, a series…
DDW 2025
A new DDW 2025 study reveals a surprising truth: most post-polypectomy colorectal…
With 19 million more patients now eligible for colorectal cancer screening, the…
Thought Leadership
The story of gastroenterology in 2025 is no longer about productivity or…
Gastroenterology is facing a growing anesthesia staffing mismatch—driven not just by workforce…
In a surprisingly funny and philosophical essay, The New York Times writer…